AURINIA PHARMACEUTICALS
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need. The company is currently developing voclosporin, an investigational drug, for the potential treatment of lupus nephritis, focal segmental glomerulosclerosis, and Dry Eye Syndrome.
AURINIA PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care Medical Therapeutics
Founded:
2011-01-01
Address:
Victoria, British Columbia, Canada
Country:
Canada
Website Url:
http://www.auriniapharma.com
Total Employee:
251+
Status:
Active
Contact:
+1 (250) 744-2487
Email Addresses:
[email protected]
Total Funding:
658.46 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache
Current Advisors List
Current Employees Featured
![]()
![]()
Founder
![]()
![]()
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2013-02-05 | Isotechnika Pharma | Isotechnika Pharma acquired by Aurinia Pharmaceuticals | N/A |
Investors List
Apple Tree Partners
Apple Tree Partners investment in Post-IPO Equity - Aurinia Pharmaceuticals
Lumira Ventures
Lumira Ventures investment in Post-IPO Equity - Aurinia Pharmaceuticals
![]()
Redmile Group
Redmile Group investment in Post-IPO Equity - Aurinia Pharmaceuticals

ILJIN Life Science
ILJIN Life Science investment in Post-IPO Equity - Aurinia Pharmaceuticals
![]()
Difference Capital
Difference Capital investment in Post-IPO Equity - Aurinia Pharmaceuticals
![]()
Great Point Partners
Great Point Partners investment in Post-IPO Equity - Aurinia Pharmaceuticals
![]()
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Aurinia Pharmaceuticals
![]()
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Aurinia Pharmaceuticals
![]()
venBio Partners
venBio Partners investment in Post-IPO Equity - Aurinia Pharmaceuticals
Lumira Ventures
Lumira Ventures investment in Post-IPO Equity - Aurinia Pharmaceuticals
Official Site Inspections
http://www.auriniapharma.com Semrush global rank: 1.9 M Semrush visits lastest month: 11.51 K
- Host name: 198.202.211.1
- IP address: 198.202.211.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
